Sign In
Buy ARAY
$0.268
-0.0169 (-5.93%)
At Close: Jul 31, 2026
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
05:30pm, Tuesday, 27'th Feb 2024
Company to Take Part in Fireside Chat Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST MADISON, Wis. , Feb. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its particip
7 Screaming Stock Buys for Under $5
02:48pm, Wednesday, 21'st Feb 2024
While most financial advisors will probably steer you away from under $5 stocks, they have their benefits. Just like in football – the American kind – you can't just run up the gut.
Three Reasons to Retain Accuray (ARAY) Stock in Your Portfolio
12:31pm, Tuesday, 20'th Feb 2024
The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
07:35am, Tuesday, 13'th Feb 2024
Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is a center of excellence and recognized leader in the treatment of cancer in the province of Quebec The Radixact System is eq
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
05:30pm, Monday, 05'th Feb 2024
MADISON, Wis. , Feb. 5, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, whi
Accuray (ARAY) Q2 Earnings Lag Estimates, Gross Margin Contracts
11:36am, Thursday, 01'st Feb 2024
Despite robust Services revenues, Accuray (ARAY) reports dismal second-quarter fiscal 2024 results.
Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript
10:03pm, Wednesday, 31'st Jan 2024
Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript
Accuray (ARAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
07:36pm, Wednesday, 31'st Jan 2024
The headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics
10:21am, Tuesday, 30'th Jan 2024
Besides Wall Street's top -and-bottom-line estimates for Accuray (ARAY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Accuray's (ARAY) CyberKnife S7 to Enhance Radiation Treatment
11:46am, Monday, 29'th Jan 2024
Accuray's (ARAY) latest generation CyberKnife S7 System is expected to boost the cancer treatment capabilities of the Providence Swedish Radiosurgery Center.
Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024
05:30pm, Tuesday, 16'th Jan 2024
MADISON, Wis. , Jan. 16, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023, during a conferenc
Here's Why You Should Retain Accuray (ARAY) Stock for Now
12:47pm, Monday, 08'th Jan 2024
The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.
Accuray (ARAY) Launches VitalHold in Japan for Use With Radixact
09:01am, Wednesday, 06'th Dec 2023
Accuray's (ARAY) VitalHold is likely to transform breast cancer treatment in Japan by integrating SGRT for precise radiotherapy. It may become a game-changer for patients and medical staff.
Accuray (ARAY) Q1 Earnings In-Line With Estimates, Revenues Top
12:46pm, Wednesday, 08'th Nov 2023
Accuray (ARAY) reports a solid fiscal first quarter top line on the back of robust Product revenues.
Accuray Incorporated (ARAY) Q1 2024 Earnings Call Transcript
10:46pm, Tuesday, 07'th Nov 2023
Accuray Incorporated (NASDAQ:ARAY ) Q1 2024 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pe
